Clinical commissioning policy: prescribing of gender affirming hormones (masculinising or feminising hormones) as part of the children and young people’s gender service
Gender affirming hormones are available as a routine commissioning treatment option for young people with continuing gender incongruence / gender dysphoria from around their 16th birthday subject to individuals meeting eligibility and readiness criteria set out in this document.
Source:
NHS England
SPS commentary:
Puberty suppressing hormones are not available as a routine commissioning treatment option for treatment of children and young people who have gender incongruence / gender dysphoria as there is not enough evidence to support their safety or clinical effectiveness.